Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperamylasaemia
ADR ID BADD_A06139
ADR Hierarchy
14      Metabolism and nutrition disorders
14.11      Metabolism disorders NEC
14.11.01      Metabolic disorders NEC
14.11.01.003      Hyperamylasaemia
Description A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes. | A benign condition in which the circulating AMYLASES are of high molecular masses, macroamylases. Macroamylases are amylase-plasma protein complexes, usually with immunoglobulins. Macroamylases cannot be cleared by the renal glomeruli. [MeSH]
MedDRA Code 10062770
MeSH ID D034321
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hyperamylasaemia | Hyperamylasemia | Macroamylasemia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00008Abacavir--
BADD_D00010Abacavir sulfate--
BADD_D00079Alogliptin0.000399%
BADD_D00405Ceftriaxone0.011141%
BADD_D00551Cyclosporine--
BADD_D00858Everolimus0.000153%
BADD_D00931Fluorouracil0.000184%
BADD_D01242Lamivudine--
BADD_D01393Meropenem0.000049%
BADD_D01498Morphine0.000223%
BADD_D01567Nilotinib0.000112%
BADD_D01952Ritonavir--
BADD_D02026Simvastatin0.000007%
BADD_D02058Sorafenib0.000112%
BADD_D02100Sunitinib0.000112%
BADD_D02165Teriflunomide--
BADD_D02226Tipranavir--
BADD_D02227Tipranavir disodium--
The 1th Page    1    Total 1 Pages